31. LBA3IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC). (24th November 2019) Authors: Cheng, A-L; Qin, S; Ikeda, M; Galle, P; Ducreux, M; Zhu, A; Kim, T-Y; Kudo, M; Breder, V; Merle, P; Kaseb, A; Li, D; Verret, W; Xu, Z; Hernandez, S; Liu, J; Huang, C; Mulla, S; Lim, H Y; Finn, R Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. LBA4Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: An update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC). (24th November 2019) Authors: Untch, M; Geyer, C E; Huang, C; Loibl, S; Wolmark, N; Mano, M S; von Minckwitz, G; Brufsky, A; Pivot, X; Polikoff, J; Fontana, A; Kaufman, B; Alcedo, J C; Boulet, T; Liu, H; Song, C; Mamounas, E P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. LBA7Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC). (24th November 2019) Authors: Hsu, C-H; Lee, M S; Lee, K-H; Numata, K; Stein, S; Verret, W; Hack, S; Spahn, J; Liu, B; Huang, C; He, R; Ryoo, B-Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Liposomal docosahexaenoic acid halts atherosclerosis progression. (3rd October 2022) Authors: Chong, S Y; Wang, X; Van Bloois, L; Huang, C; Yu, X; Sayed, N; Zhang, S; Ting, H J; Thiam, C H; Lim, S Y; Lim, H Y; Zharkova, O; Angeli, V; Storm, G; Wang, J W Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. P122Cardiac-specific deletion of Janus kinase 2 (JAK2) reveals marked cardiac pathology indicative of hypertrophy, heart failure and sudden cardiac death. (15th July 2014) Authors: Gan, X; Rajapurohitam, V; Huang, C; Xue, J; Chow, J; Karmazyn, M Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. P131 Factors associated with Referral to Sleep Clinic and Diagnosis of Obstructive Sleep Apnoea in Pregnant People with Class III Obesity. (9th November 2022) Authors: Warhurst, S; Sethna, F; Georgousopoulou, E; Huang, C Journal: Sleep advances Issue: Volume 3(2022)Supplement 1 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Preparing superhydrophobic surfaces with very low contact angle hysteresis. (1st September 2013) Authors: Huang, Y F; Huang, C; Zhong, Y L; Yi, S P Journal: Surface engineering Issue: Volume 29:Number 8(2013) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Preparing superhydrophobic surfaces with very low contact angle hysteresis. (September 2013) Authors: Huang, Y F; Huang, C; Zhong, Y L; Yi, S P Journal: Surface engineering Issue: Volume 29:Number 8(2013) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Psittacosis masquerading as rheumatic fever. Issue 6114 (18th March 1978) Authors: Simpson, R W; Huang, C; Grahame-Smith, D G Journal: BMJ Issue: Volume 1:Issue 6114(1978) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. P–363 Poor Ovarian Response is Associated with Anti-ovarian Antibody, and Pro-inflammatory Immune Responses in Women Underwent Assisted Reproductive Technology Cycles. (6th August 2021) Authors: Huang, C; Alsubki, L; Sung, N; Kwak-Kim, J Journal: Human reproduction Issue: Volume 36:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗